Synthesis, In Vitro Biological Evaluation, and Molecular Docking Studies of Novel Biphenyl Chalcone Derivatives as Antimicrobial Agents

References

• S. K. Yazdan, D. V. Sagar, and A. B. Shaik, “Chemical and Biological Potentials of Chalcones: A Review,” OMCIJ 1, no. 1 (2015): 555553.
   Google Scholar
• B. Mathew, G. E. Mathew, G. Uçar, I. Baysal, J. Suresh, S. Mathew, A. Haridas, and V. Jayaprakash, “Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives,” Chemistry & Biodiversity 13, no. 8 (2016): 1046–52.
   PubMed Web of Science ®Google Scholar
• R. Arif, M. Rana, S. Yasmeen, A. Md S. Khan, M. Abid, and M. S. Khan, Rahisuddin, “Facile Synthesis of Chalcone Derivatives as Antibacterial Agents: Synthesis, DNA Binding, Molecular Docking, DFT and Antioxidant Studies,” Journal of Molecular Structure 1208 (2020): 127905.
   Web of Science ®Google Scholar
• B. Mathew, D. G. T. Parambi, V. S. Sivasankarapillai, M. S. Uddin, J. Suresh, G. E. Mathew, M. Joy, A. Marathakam, and S. V. Gupta, “Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review,” CNS & Neurological Disorders Drug Targets 18, no. 6 (2019): 432–45.
   PubMed Web of Science ®Google Scholar
• N. A. Hamed, M. I. Marzouk, M. F. Ismail, and M. H. Hekal, “N'-(1-([1,1'-Biphenyl]-4-yl)Ethylidene)-2-Cyanoacetohydrazide as Scaffold for the Synthesis of Diverse Heterocyclic Compounds as Prospective Antitumor and Antimicrobial Activities,” Synthetic Communications 49, no. 21 (2019): 1–3029.
   Web of Science ®Google Scholar
• M. F. Ismail and A. A. El-Sayed, “Synthesis of Diverse Novel Compounds with Anticipated Antitumor Activities Starting with Biphenyl Chalcone,” Journal of Heterocyclic Chemistry 57, no. 7 (2020): 2990–3001.
   Web of Science ®Google Scholar
• S. Kaya, H. Gökce, T. Arslan, and G. Alpaslan, “Synthesis, Spectroscopic Characterization, DFT Computations, Nonlinear Optical Profile and Molecular Docking Study of a Novel Chalcone Derivative,” Journal of Molecular Structure 1202 (2020): 127270.
   Web of Science ®Google Scholar
• S. M. Levy and B. Marshall, “Antibacterial Resistance Worldwide: Causes, Challenges and Responses,” Nature Medicine 10, no. 12 Suppl (2004): S122–S129.
   PubMed Web of Science ®Google Scholar
• A. L. Alves Borges Leal, P. Teixeira da Silva, M. Nunes da Rocha, E. M. Marinho, E. S. Marinho, M. M. Marinho, P. N. Bandeira, C. E. Sampaio Nogueira, H. M. Barreto, A. M. Rodrigues Teixeira, et al. “Potentiating Activity of Norfloxacin by Synthetic Chalcones against NorA Overproducing Staphylococcus Aureus,” Microbial Pathogenesis 155 (2021): 104894.
   PubMed Web of Science ®Google Scholar
• Z. H. Chen, C. J. Zheng, L. P. Sun, and H. R. Piao, “Synthesis of New Chalcone Derivatives Containing a Rhodanine-3-Acetic Acid Moiety with Potential anti-Bacterial Activity,” European Journal of Medicinal Chemistry 45, no. 12 (2010): 5739–43.
   PubMed Web of Science ®Google Scholar
• M. I. Abdullah, A. Mahmood, M. Madni, S. Masood, and M. Kashif, “Synthesis, Characterization, Theoretical, anti-Bacterial and Molecular Docking Studies of Quinoline Based Chalcones as a DNA Gyrase Inhibitor,” Bioorganic Chemistry 54 (2014): 31–7.
   PubMed Web of Science ®Google Scholar
• S. M. Karthikeyan, B. S. Holla, and N. S. Kumari, “Synthesis and Antimicrobial Studies on Novel Chloro-Fluorine Containing Hydroxy Pyrazolines,” European Journal of Medicinal Chemistry. 42, no. 1 (2007): 30–6.
   PubMed Web of Science ®Google Scholar
• D. Batovska, S. Parushev, B. Stamboliyska, I. Tsvetkova, M. Ninova, and H. Najdenski, “Examination of Growth Inhibitory Properties of Synthetic Chalcones for Which Antibacterial Activity Was Predicted,” European Journal of Medicinal Chemistry 44, no. 5 (2009): 2211–8.
   PubMed Web of Science ®Google Scholar
• S. Burmaoglu, O. Algul, A. Gobek, D. A. Anil, M. Ulger, B. G. Erturk, E. Kaplan, A. Dogen, and G. Aslan, “Design of Potent Fluoro-Substituted Chalcones as Antimicrobial Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 32, no. 1 (2017): 490–5.
   PubMed Web of Science ®Google Scholar
• Z. J. Jain, P. S. Gide, and R. S. Kankate, “Biphenyls and Their Derivatives as Synthetically and Pharmacologically Important Aromatic Structural Moieties,” Arabian Journal of Chemistry 10, no. 2 (2017): S2051–S2066.
   Google Scholar
• L. Zhu, J. Duquette, and M. Zhang, “An Improved Preparation of Arylboronates:  Application in One-Pot Suzuki Biaryl synthesis,” The Journal of Organic Chemistry 68, no. 9 (2003): 3729–32.
   PubMed Web of Science ®Google Scholar
• X. Dong, L. Du, Z. Pan, T. Liu, B. Yang, and Y. Hu, “Synthesis and Biological Evaluation of Novel Hybrid Chalcone Derivatives as Vasorelaxant Agents,” European Journal of Medicinal Chemistry 45, no. 9 (2010): 3986–92.
   PubMed Web of Science ®Google Scholar
• C. Zhuang, W. Zhang, C. Sheng, W. Zhang, C. Xing, and Z. Miao, “Chalcone: A Privileged Structure in Medicinal Chemistry,” Chemical Reviews 117, no. 12 (2017): 7762–810.
   PubMed Web of Science ®Google Scholar
• S. Burmaoglu, E. A. Kazancioglu, R. Kaya, M. Kazancioglu, M. Karaman, O. Algul, and I. Gulcin, “Synthesis of Novel Organohalogen Chalcone Derivatives and Screening of Their Molecular Docking Study and Some Enzymes Inhibition Effects,” Journal of Molecular Structure 1208 (2020): 127868.
   Web of Science ®Google Scholar
• E. Harder, W. Damm, J. Maple, C. Wu, M. Reboul, J. Y. Xiang, L. Wang, D. Lupyan, M. K. Dahlgren, J. L. Knight, et al. “OPLS3: A Force Field Providing Broad Coverage of Druglike Small Molecules and Proteins,” Journal of Chemical Theory and Computation 12, no. 1 (2016): 281–96.
   PubMed Web of Science ®Google Scholar
• M. A. Salem, A. Ragab, A. A. Askar, A. El-Khalafawy, and A. H. Makhlouf, “ One-Pot Synthesis and Molecular Docking of Some New Spiropyranindol-2-One Derivatives as Immunomodulatory Agents and In Vitro Antimicrobial Potential with DNA Gyrase Inhibitor,” European Journal of Medicinal Chemistry 188 (2020): 111977.
   PubMed Web of Science ®Google Scholar
• G. M. Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, and W. Sherman, “Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments,” Journal of Computer-Aided Molecular Design 27, no. 3 (2013): 221–34.
   PubMed Web of Science ®Google Scholar
• R. A. Friesner, R. B. Murphy, M. P. Repasky, L. L. Frye, J. R. Greenwood, T. A. Halgren, P. C. Sanschagrin, and D. T. Mainz, “Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes,” Journal of Medicinal Chemistry 49, no. 21 (2006): 6177–96.
   PubMed Web of Science ®Google Scholar
• Z. Nowakowska, “A Review of Anti-Infective and Anti-Inflammatory Chalcones,” European Journal of Medicinal Chemistry 42, no. 2 (2007): 125–37.
   PubMed Web of Science ®Google Scholar
• M. Xu, P. Wu, F. Shen, J. Y. Ji, and K. P. Rakesh, “Chalcone Derivatives and Their Antibacterial Activities: Current Development,” Bioorganic Chemistry 91 (2019): 103133.
   PubMed Web of Science ®Google Scholar
• J. Z. Patel, T. Parkkari, T. Laitinen, A. A. Kaczor, S. M. Saario, J. R. Savinainen, D. Navia-Paldanius, M. Cipriano, J. Leppänen, I. O. Koshevoy, et al. “Chiral 1,3,4-Oxadiazol-2-Ones as Highly Selective FAAH Inhibitors,” Journal of Medicinal Chemistry 56, no. 21 (2013): 8484–96.
   PubMed Web of Science ®Google Scholar
• G. L. Woods, J. A. Washington, “Antibacterial Susceptibility Tests: Dilution and Disk Diffusion Methods,” in Manual of Clinical Microbiology, edited by P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken, 6th ed. (Washington, DC: American Society for Microbiology, 1995), 1327–1341.
   Google Scholar
• J. H. Jorgensen and M. J. Ferraro, “Antimicrobial Susceptibility Testing: General Principles and Contemporary Practices,” Clinical Infectious Diseases26, no. 4 (1998): 973–80.
   PubMed Web of Science ®Google Scholar
• T. R. Blower, B. H. Williamson, R. J. Kerns, and J. M. Berger, “Crystal Structure and Stability of Gyrase-Fluoroquinolone Cleaved Complexes from Mycobacterium Tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America 113, no. 7 (2016): 1706–13.
   PubMed Web of Science ®Google Scholar
• H. H. H. Mohammed, E. M. N. Abdelhafez, S. H. Abbas, G. A. I. Moustafa, G. Hauk, J. M. Berger, S. Mitarai, M. Arai, R. M. Abd El-Baky, and G. E. A. Abuo-Rahma, “Design, Synthesis and Molecular Docking of New N-4-Piperazinyl Ciprofloxacin-Triazole Hybrids with Potential Antimicrobial Activity,” Bioorganic Chemistry 88 (2019): 102952.
   PubMed Web of Science ®Google Scholar
• M. Thangaraj, R. M. Gengan, B. Ranjan, and R. Muthusamy, “Synthesis, Molecular Docking, Antimicrobial, Antioxidant and Toxicity Assessment of Quinoline Peptides,” Journal of Photochemistry and Photobiology B, Biology 178, no. 2018 (2018): 287–95.
   PubMedGoogle Scholar